4 HealthTech Stocks Trending Now APLS stock, SGRY stock, ATEC stock, RCKT stock
Powered by healthtechmovers.com
According to healthtechmovers.com, there are a few trending healthtech stocks that have recently received buy ratings and showing positive investor sentiment, as well as news headlines. With that said, the editors over at healthtechmovers.com, are adding the stocks below to their healthtech stock watchlist. That staff here at finmarketnews.com, will continue to monitor these healthtech companies to see if the momentum continues. FinMarketNews.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more..
Recent APLS Stock Price: $42.30
Summary: Apellis Pharmaceuticals, Inc. is a clinical-stage biotech focused on the development of novel therapeutics, which work through the inhibition of the complement system, specially targeting the C3 protein of the complement system to treat autoimmune and inflammatory diseases.
Derek Archila analyst at Wells Fargo reiterates coverage on Apellis Pharmaceuticals, Inc. (APLS) stock in the energy sector with a Hold rating and has set APLS's stock price target at $57.
TipRanks.com reports that Apellis Pharmaceuticals, Inc. currently has 5 analysts offering 12-month price targets on APLS and the consensus is a Buy rating with an average stock price target of $74.80. The most recent APLS stock price we have is $42.30 and we are not making any APLS forecasts at this time.
In addition, TradingView issued a rating for APLS over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has short-term outlook. Remember, securities are volatile, so please do your own research on APLS. finmarketnews.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on APLS, please click here >>
Surgery Partners, Inc., SGRY
Recent SGRY Stock Price: $27.17
Summary: Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee.
Whit Mayo analyst at Leerink Partners reiterates coverage on Surgery Partners, Inc. (SGRY) stock in the energy sector with a Buy rating and has set SGRY's stock price target at $41.
TipRanks.com reports that Surgery Partners, Inc. currently has 5 analysts offering 12-month price targets on SGRY and the consensus is a Buy rating with an average stock price target of $43.00. The most recent SGRY stock price we have is $27.17 and we are not making any SGRY forecasts at this time.
In addition, TradingView issued a rating for SGRY over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has short-term outlook. Remember, securities are volatile, so please do your own research on SGRY. finmarketnews.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on SGRY, please click here >>
Alphatec Holdings, Inc., ATEC
Recent ATEC Stock Price: $10.60
Summary: Alphatec Holdings, Inc. is a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. The Company's principal product offering includes a variety of spinal implant products and systems consisted of components, such as spine screws and rods, spinal spacers, plates, and various biologics offerings. Alphatec Holdings, Inc. is headquartered in Carlsbad, California.
Matthew O'Brien analyst at Piper Sandler reiterates coverage on Alphatec Holdings, Inc. (ATEC) stock in the energy sector with a Buy rating and has set ATEC's stock price target at $17.
TipRanks.com reports that Alphatec Holdings, Inc. currently has 5 analysts offering 12-month price targets on ATEC and the consensus is a Buy rating with an average stock price target of $23.60. The most recent ATEC stock price we have is $10.60 and we are not making any ATEC forecasts at this time.
In addition, TradingView issued a rating for ATEC over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has short-term outlook. Remember, securities are volatile, so please do your own research on ATEC. finmarketnews.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on ATEC, please click here >>
Rocket Pharmaceuticals, Inc., RCKT
Recent RCKT Stock Price: $22.98
Summary: Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company. It focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket Pharmaceuticals Inc., formerly known as Inotek Pharmaceuticals Corporation, is based in LEXINGTON, United States.
Cory Jubinville, analyst at LifeSci Capital reiterates coverage on Rocket Pharmaceuticals, Inc. (RCKT) stock in the energy sector with a Buy rating and has set RCKT's stock price target at $53.
TipRanks.com reports that Rocket Pharmaceuticals, Inc. currently has 4 analysts offering 12-month price targets on RCKT and the consensus is a Buy rating with an average stock price target of $50.75. The most recent RCKT stock price we have is $22.98 and we are not making any RCKT forecasts at this time.
In addition, TradingView issued a rating for RCKT over the next month, Barchart.com has a sell rating and Yahoo! Finance has short-term outlook. Remember, securities are volatile, so please do your own research on RCKT. finmarketnews.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on RCKT, please click here >>
The editors at finmarketnews.com use a variety of research tools to generate our watchlists and research reports. One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. TipRanks.com tracks and measures the performance of over 50,000 financial experts. The TipRanks Star RankingTM is calculated based on expert success rate, average return and statistical significance. Get more from TipRanks.com here >>
FinMarketNews.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to FinMarketNews.com.
==============================================================================